+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immucor Inc - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 24 Pages
  • December 2023
  • GlobalData
  • Immucor Inc
  • ID: 2254371
Immucor Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.


Immucor Inc (Immucor) provides transfusion and transplantation diagnostic products. The company develops, manufactures and markets serology-based reagents and instruments for pre-transfusion typing and screening of blood; and assays for pre-transplant typing and screening and post-transplant monitoring. It also offers coagulation products to help determine a patient’s risk of excessive bleeding and antibody count in thrombosis. The company develops molecular and antibody-based assays using its ELISA and xMAP technology. It serves hospitals, donor centers and reference laboratories worldwide. The company markets products directly and through a network of distributors in the US, Belgium, India, Italy, Japan, Portugal, Canada, France, Germany, Spain and the UK and rest of the world. Immucor is headquartered in Norcross, Georgia, the US.

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with a detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Immucor Inc - Key Facts
  • Immucor Inc - Key Employees
  • Immucor Inc - Key Employee Biographies
  • Immucor Inc - Major Products and Services
  • Immucor Inc - History
  • Immucor Inc - Company Statement
  • Immucor Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Immucor Inc - Business Description
  • Immucor Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Immucor Inc - Strengths
  • Immucor Inc - Weaknesses
  • Immucor Inc - Opportunities
  • Immucor Inc - Threats
  • Immucor Inc - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Immucor Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Immucor Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Immucor Inc, Recent Deals Summary
Section 4 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Immucor Inc, Key Facts
  • Immucor Inc, Key Employees
  • Immucor Inc, Key Employee Biographies
  • Immucor Inc, Major Products and Services
  • Immucor Inc, History
  • Immucor Inc, Subsidiaries
  • Immucor Inc, Key Competitors
  • Immucor Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Immucor Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • Immucor Inc, Recent Deals Summary
List of Figures
  • Immucor Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • Immucor Inc, Medical Equipment, Deals by Type, 2017 to YTD 2023



Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Thermo Fisher Scientific Inc
  • SurModics Inc
  • Ortho Clinical Diagnostics Holdings Plc
  • Bio-Rad Laboratories Inc
  • Abbott Laboratories